UBS Group’s Invesco Dorsey Wright Healthcare Momentum ETF PTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
26,646
-10,045
-27% -$489K ﹤0.01% 5339
2025
Q4
$1.82M Sell
36,691
-4,781
-12% -$235K ﹤0.01% 5062
2025
Q3
$1.83M Sell
41,472
-9,927
-19% -$390K ﹤0.01% 5045
2025
Q2
$2M Buy
51,399
+6,339
+14% +$239K ﹤0.01% 4821
2025
Q1
$1.78M Sell
45,060
-3,843
-8% -$159K ﹤0.01% 4810
2024
Q4
$1.96M Buy
48,903
+1,242
+3% +$55.4K ﹤0.01% 4734
2024
Q3
$2.21M Sell
47,661
-4,320
-8% -$196K ﹤0.01% 3885
2024
Q2
$2.23M Buy
51,981
+203
+0.4% +$8.52K ﹤0.01% 3662
2024
Q1
$2.28M Sell
51,778
-3,469
-6% -$147K ﹤0.01% 3820
2023
Q4
$2.16M Sell
55,247
-3,296
-6% -$110K ﹤0.01% 3734
2023
Q3
$1.97M Sell
58,543
-2,468
-4% -$91.4K ﹤0.01% 3454
2023
Q2
$2.48M Sell
61,011
-12,915
-17% -$514K ﹤0.01% 3327
2023
Q1
$2.77M Sell
73,926
-12,933
-15% -$506K ﹤0.01% 3082
2022
Q4
$3.56M Sell
86,859
-14,844
-15% -$603K ﹤0.01% 2819
2022
Q3
$4.11M Buy
101,703
+6,120
+6% +$258K ﹤0.01% 2536
2022
Q2
$3.66M Sell
95,583
-24,852
-21% -$1M ﹤0.01% 2635
2022
Q1
$5.4M Sell
120,435
-52,092
-30% -$2.28M ﹤0.01% 2464
2021
Q4
$8.91M Sell
172,527
-14,253
-8% -$741K ﹤0.01% 2252
2021
Q3
$10M Buy
186,780
+1,137
+0.6% +$63.7K ﹤0.01% 2028
2021
Q2
$10.3M Sell
185,643
-124,500
-40% -$6.48M ﹤0.01% 2006
2021
Q1
$16.2M Sell
310,143
-74,196
-19% -$4.16M 0.01% 1583
2020
Q4
$20.5M Buy
384,339
+131,301
+52% +$6.53M 0.01% 1331
2020
Q3
$11.5M Buy
253,038
+4,665
+2% +$206K ﹤0.01% 1551
2020
Q2
$10.1M Buy
248,373
+55,884
+29% +$1.98M ﹤0.01% 1492
2020
Q1
$5.47M Buy
192,489
+66,045
+52% +$2.01M ﹤0.01% 1851
2019
Q4
$4.03M Sell
126,444
-9,795
-7% -$278K ﹤0.01% 2812
2019
Q3
$3.55M Sell
136,239
-22,965
-14% -$658K ﹤0.01% 2712
2019
Q2
$4.68M Sell
159,204
-258,417
-62% -$6.93M ﹤0.01% 2379
2019
Q1
$11.1M Buy
417,621
+82,053
+24% +$2.16M ﹤0.01% 1601
2018
Q4
$7.96M Sell
335,568
-288,576
-46% -$7.77M ﹤0.01% 1763
2018
Q3
$20.5M Buy
624,144
+209,190
+50% +$6.49M 0.01% 1190
2018
Q2
$12.1M Sell
414,954
-687
-0.2% -$19.1K 0.01% 1577
2018
Q1
$10.6M Buy
415,641
+53,856
+15% +$1.39M ﹤0.01% 1639
2017
Q4
$8.69M Sell
361,785
-170,940
-32% -$3.94M ﹤0.01% 1845
2017
Q3
$12M Buy
532,725
+466,509
+705% +$9.84M 0.01% 1468
2017
Q2
$1.37M Sell
66,216
-41,931
-39% -$774K ﹤0.01% 3346
2017
Q1
$1.94M Sell
108,147
-7,218
-6% -$125K ﹤0.01% 2970
2016
Q4
$1.85M Sell
115,365
-831
-0.7% -$13.5K ﹤0.01% 2977
2016
Q3
$2.04M Sell
116,196
-16,302
-12% -$264K ﹤0.01% 2823
2016
Q2
$1.97M Buy
132,498
+7,611
+6% +$113K ﹤0.01% 2789
2016
Q1
$1.8M Sell
124,887
-492,888
-80% -$7.11M ﹤0.01% 2771
2015
Q4
$11.3M Sell
617,775
-95,163
-13% -$1.75M 0.01% 1314
2015
Q3
$12.9M Buy
712,938
+123,726
+21% +$2.57M 0.01% 1192
2015
Q2
$12.5M Buy
589,212
+3,549
+0.6% +$73.3K 0.01% 1304
2015
Q1
$11.8M Buy
585,663
+111,390
+23% +$2.14M 0.01% 1338
2014
Q4
$8.58M Buy
+474,273
New +$8.22M 0.01% 1620

Other funds holding PTH

UBS Group's PTH Position: Q1 2026 in Review

UBS Group reduced its Invesco Dorsey Wright Healthcare Momentum ETF (PTH) stake by 27% in Q1 2026, selling an estimated $489K and leaving 26,646 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5339.

UBS Group first reported a position in PTH in Q4 2014 and has held it in 46 quarters since. The position peaked at $20.5M in Q3 2018. 62 funds tracked by Wall St. Rank hold PTH as of Q1 2026.

  • UBS Group held 26,646 shares of Invesco Dorsey Wright Healthcare Momentum ETF worth $1.31M as of Q1 2026.
  • UBS Group sold 10,045 Invesco Dorsey Wright Healthcare Momentum ETF shares in Q1 2026, an estimated $489K.
  • Invesco Dorsey Wright Healthcare Momentum ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5339 holding.
  • UBS Group first reported a position in Invesco Dorsey Wright Healthcare Momentum ETF in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Invesco Dorsey Wright Healthcare Momentum ETF position peaked at $20.5M in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Invesco Dorsey Wright Healthcare Momentum ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.